Published in Med Hypotheses on March 21, 2007
Corneal neovascularization: an anti-VEGF therapy review. Surv Ophthalmol (2012) 1.21
Post-trabeculectomy topical bevacizumab preventing bleb failure: a preliminary study. J Ocul Biol Dis Infor (2013) 0.77
Understanding lymphangiogenesis in knockout models, the cornea, and ocular diseases for the development of therapeutic interventions. Surv Ophthalmol (2015) 0.77
Comparison of corneal thickness measurements using Galilei, HR Pentacam, and ultrasound. Cornea (2010) 1.04
Intravitreal injection of bevacizumab (Avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II. Retina (2009) 0.95
Bevacizumab (Avastin) as a potential novel adjunct in the management of pterygia. Med Hypotheses (2007) 0.94
Bilateral spontaneous rupture of posterior capsule in posterior polar cataract. Clin Experiment Ophthalmol (2008) 0.94
Effect of intravitreal bevacizumab on retrobulbar blood flow in injected and uninjected fellow eyes of patients with neovascular age-related macular degeneration. Retina (2012) 0.93
Cone location and correction of keratoconus with rigid gas-permeable contact lenses. Cont Lens Anterior Eye (2011) 0.89
Effect of anterior chamber air bubble on prevention of experimental Staphylococcus epidermidis endophthalmitis. Graefes Arch Clin Exp Ophthalmol (2009) 0.81
Debate on the various anti-vascular endothelial growth factor drugs. Indian J Ophthalmol (2008) 0.75
Focus on triamcinolone acetonide as an adjunct to glaucoma filtration surgery. Med Hypotheses (2006) 0.75